Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 3]
Phase 3 trial evaluating radiation therapy with or without temozolomide in older adults with newly diagnosed glioblastoma multiforme has com…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
Clinical trial evaluating everolimus, temozolomide, and radiation therapy for newly diagnosed glioblastoma multiforme (Phase 1/2) completed …
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme [Phase 2]
Phase II study of rindopepimut (CDX-110) in glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Engagement of Patients With Advanced Cancer [NA]
Clinical trial update noting engagement of patients with advanced cancer; status completed and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme [Phase 2]
Phase 2 study results for Antineoplaston therapy in adults with residual, recurrent, or progressive glioblastoma multiforme.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: NOA-12: BIBF1120 and R-RT in Glioblastoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating BIBF1120 (nintedanib) with radiotherapy for glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients [Phase 2]
Phase II trial of axitinib (AG-013736) in elderly patients with glioblastoma multiforme has been terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating gossypol for progressive or recurrent glioblastoma multiforme; results have been posted.
-
CLINICAL_TRIALS research · 2017-07-11Clinical Trial Update: Hypofractionated Radiation Therapy for Glioblastoma [Phase 2]
Clinical trial update on a Phase 2 hypofractionated radiation therapy study for glioblastoma. The current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating dasatinib in combination with bevacizumab for recurrent or progressive high-grade glioma or glioblastoma multiforme…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
Phase 1/2 trial evaluating dasatinib or placebo with radiation therapy and temozolomide in newly diagnosed glioblastoma multiforme has compl…
-
FDA approval · 2017-04-26FDA Approved: TEMOZOLOMIDE — Original Application (CivicaScript LLC)
FDA approved Temozolomide under CivicaScript LLC's original application (ANDA207658), marking the approval of a generic Temozolomide product…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 study of MEDI-575 in subjects with recurrent glioblastoma multiforme completed; results were posted on 2017-04-06.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating bi-weekly temozolomide plus bevacizumab in adults with recurrent glioblastoma multiforme and recurrent gliosarcom…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 trial of ramucirumab or IMC-3G3 (anti-PDGFR alpha antibody) in recurrent glioblastoma multiforme has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma [Phase 1]
This Phase 1 trial investigates a dose-per-fraction escalation of hypofractionated IMRT with temozolomide for newly diagnosed glioblastoma a…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating a biological therapy with radiation for newly diagnosed glioblastoma multiforme has been terminated. Results were…
-
FDA approval · 2017-02-27FDA Approved: TEMOZOLOMIDE — Original Application (Accord Healthcare Inc.)
FDA approved an original application for temozolomide by Accord Healthcare Inc., authorizing a generic version of the cancer drug temozolomi…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
A phase 1/2 trial evaluated everolimus, temozolomide, and radiation therapy in newly diagnosed glioblastoma, with results posted after compl…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluated the combination of bevacizumab and sorafenib in patients with recurrent glioblastoma multiforme; the study is comp…
-
CLINICAL_TRIALS research · 2016-12-29Clinical Trial Update: Integrative Analysis of Human Glioblastoma Multiforme
This clinical trial update indicates that the integrative analysis study of glioblastoma multiforme is currently recruiting, sponsored by Sh…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme [Phase 1, Phase 2]
This Phase 1/2 clinical trial evaluated irinotecan with radiation therapy followed by chemotherapy for glioblastoma multiforme and has compl…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
The clinical trial evaluating the effects of radiotherapy and temozolomide on tumor vasculature and cancer stem cells in high-grade astrocyt…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma [Phase 1]
Phase 1 dose- and efficacy-finding study evaluating RO5323441 in combination with bevacizumab in patients with recurrent glioblastoma; study…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: TPI 287 in Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 trial of TPI-287 for recurrent glioblastoma multiforme was terminated; results were posted in 2016.